Search
for
Sort by
Research 30 of 50
- Gonadotropin-Releasing Hormone Agonist Treatment in Postmenopausal Women with Hyperandrogenism of Ovarian Origin
- Presentation of a meningioma in a transwoman after nine years of cyproterone acetate and estradiol intake: case report and literature review
- Hypothalamic hamartoma with pubertas precox and gelastic seizure in a boy (Case Report)
- Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis
- Finasteride
- Adverse effects of common medications on male fertility
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- Endocrine Therapy–Induced Alopecia in Patients With Breast Cancer
- Androgenic Effects on Ventricular Repolarization
- Alopecia With Endocrine Therapies in Patients With Cancer
- Spinal and bulbar muscular atrophy: pathogenesis and clinical management
- 17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome
- ANTIANDROGEN THERAPY IN DERMATOLOGY
- Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women
- Cross-sex hormone therapy for gender dysphoria
- Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study
- Evaluation and Treatment of Gender Dysphoria to Prepare for Gender Confirmation Surgery
- From gene to therapy in spinal and bulbar muscular atrophy: Are we there yet?
- Recent discoveries and developments of androgen receptor based therapy for prostate cancer
- Recommendations of endocrine treatment for patients with gender dysphoria
- Nanomilled Oral Testosterone Plus Dutasteride Effectively Normalizes Serum Testosterone in Normal Men With Induced Hypogonadism
- COVID‐19, androgens, and androgenic alopecia
- A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol
- A Phase 3, Open-Label, Single-Arm Trial of the Efficacy and Safety of Triptorelin 6-Month Formulation in Chinese Children with Central Precocious Puberty
- Clinical Utility of GnRH Analogues in Female Androgen Excess: Highlighting Diagnostic and Therapeutic Applications
- Treatment of hyperandrogenism in polycystic ovary syndrome
- A Comprehensive Review of Management of Patients with Infertility having Polycystic Ovarian Syndrome
- Drug-induced male infertility: a real-world study using FAERS and EudraVigilance databases
- A Novel Nomogram for Predicting Gonadotropin-Releasing Hormone Analogue Treatment Outcome in Girls with Idiopathic Central Precocious Puberty
- Real-world pharmacovigilance insights into drug-induced risk of alopecia